S
Shandong Boan Biotechnology Co Ltd
HKEX:6955
Shandong Boan Biotechnology Co Ltd
HKEX:6955
Price:
6.98
HKD
1.9%
Market Closed
Market Cap:
HK$4.3B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
S
|
Shandong Boan Biotechnology Co Ltd
HKEX:6955
|
CN |
|
L
|
Luxurban Hotels Inc
NASDAQ:LUXH
|
US |
|
Y
|
Yatharth Hospital & Trauma Care Services Ltd
NSE:YATHARTH
|
IN |
|
Brunello Cucinelli SpA
MIL:BC
|
IT |
|
CBK Holdings Ltd
HKEX:8428
|
HK |
|
Canara Bank Ltd
NSE:CANBK
|
IN |
|
F
|
Fab Form Industries Ltd
XTSX:FBF
|
CA |
Multiples-Based Value
The Multiples-Based Value for Shandong Boan Biotechnology Co Ltd (6955) under the Base Case is hidden HKD. Compared with the current market price of 6.98 HKD, the stock appears hidden .
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Shandong Boan Biotechnology Co Ltd Multiples-Based Value
LOCKED
Multiples Across Competitors
Competitors Multiples
Shandong Boan Biotechnology Co Ltd Competitors
Shandong Boan Biotechnology Co Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
S
|
Shandong Boan Biotechnology Co Ltd
HKEX:6955
|
4B HKD | 4.7 | 110.1 | 20.8 | 45.4 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
364.8B USD | 6.1 | 88.9 | 14.7 | 20.5 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
183.3B USD | 5.1 | 24.4 | 14.2 | 14.2 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
172.3B USD | 5.9 | 20.6 | 12.8 | 15.8 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
109.7B USD | 9.3 | 28.3 | 21.2 | 22.2 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
80.4B USD | 5.7 | 18.1 | 13.5 | 15.4 | |
| NL |
|
argenx SE
XBRU:ARGX
|
41B EUR | 11.7 | 37.5 | 40.8 | 41.7 | |
| AU |
|
CSL Ltd
ASX:CSL
|
67.6B AUD | 3 | 33.6 | 11.3 | 14.2 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
